A cell biology approach to the study of diabetic vascular complications.
King
G L
GL
Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215.
Ohashi
H
H
Najak
R
R
D000818:Animals; D002478:Cells, Cultured; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology / Q000503:physiopathology; D066246:ErbB Receptors / Q000502:physiology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007335:Insulin-Like Growth Factor II / Q000502:physiology; D008833:Microcirculation / Q000166:cytology / Q000502:physiology / Q000503:physiopathology; D011956:Receptors, Cell Surface / Q000502:physiology; D017451:Receptors, Somatomedin
D011956:Receptors, Cell Surface; D017451:Receptors, Somatomedin; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D066246:ErbB Receptors